Progress of the study on cytosine arabinoside in the treatment of acute leukemia in children / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
;
(24): 165-167, 2014.
Artigo
em Chinês
| WPRIM
| ID: wpr-733278
ABSTRACT
Cytosine arabinoside (Ara-C) is one of the key chemotherapy drugs comprising all stages combined protocols during long-term chemotherapy for children with acute leukemias,which demonstrated its efficacy and safety.Along with the progress of basic and clinical researches,in Ara-C clinical dose and treatment,prevention of adverse reactions,relationship between the drug metabolism and long-term clinical results,and new nucleoside drugs have achieved remarkable results.This paper on the above fields of research,progress and trends,briefly summarized as follows.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Guia de Prática Clínica
Idioma:
Chinês
Revista:
Chinese Journal of Applied Clinical Pediatrics
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS